Use of a lifesaving drug to reverse opioid drug overdoses is growing, but not fast enough. That’s according to new research in JAMA Network Open from The Ohio State University College of Medicine, College of Public Health and the National Registry of Emergency Medical Technicians.
FDA advisory committee will meet next month to discuss Intarcia’s diabetes drug
An FDA advisory committee will meet on Sept. 21 to discuss Intarcia’s twice-rejected type 2 diabetes drug candidate and delivery system. The meeting comes nearly
August 24, 2023